Jon M. Carthy

728 total citations
20 papers, 598 citations indexed

About

Jon M. Carthy is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Jon M. Carthy has authored 20 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cell Biology and 3 papers in Immunology and Allergy. Recurrent topics in Jon M. Carthy's work include Proteoglycans and glycosaminoglycans research (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer-related gene regulation (4 papers). Jon M. Carthy is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer-related gene regulation (4 papers). Jon M. Carthy collaborates with scholars based in Canada, Sweden and Greece. Jon M. Carthy's co-authors include Bruce M. McManus, Zongshu Luo, Farshid S. Garmaroudi, Maziar Rahmani, Brian W. Wong, Thomas Abraham, Aristidis Moustakas, Anna Meredith, Lisa S. Ang and Dimitris Kletsas and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Jon M. Carthy

20 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon M. Carthy Canada 12 296 125 102 90 89 20 598
Kornelia M. Szauter United States 8 395 1.3× 92 0.7× 77 0.8× 74 0.8× 45 0.5× 10 639
Amber W. Wang United States 7 407 1.4× 63 0.5× 190 1.9× 85 0.9× 152 1.7× 9 774
P Houston United Kingdom 9 273 0.9× 76 0.6× 42 0.4× 51 0.6× 104 1.2× 16 591
M. Walraven Netherlands 10 176 0.6× 84 0.7× 87 0.9× 106 1.2× 114 1.3× 11 563
Tomohiro Nishioka Japan 7 195 0.7× 72 0.6× 75 0.7× 68 0.8× 120 1.3× 7 628
Tami L. Bach United States 9 302 1.0× 156 1.2× 61 0.6× 188 2.1× 68 0.8× 12 705
Christina Sundberg Sweden 10 309 1.0× 76 0.6× 174 1.7× 47 0.5× 34 0.4× 10 607
Sonja Gustafsson Sweden 5 284 1.0× 37 0.3× 109 1.1× 58 0.6× 67 0.8× 5 515
Mark MacEwen United States 10 208 0.7× 67 0.5× 78 0.8× 314 3.5× 108 1.2× 12 634
Katsumi Yamamori Japan 10 256 0.9× 86 0.7× 150 1.5× 52 0.6× 201 2.3× 11 635

Countries citing papers authored by Jon M. Carthy

Since Specialization
Citations

This map shows the geographic impact of Jon M. Carthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon M. Carthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon M. Carthy more than expected).

Fields of papers citing papers by Jon M. Carthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon M. Carthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon M. Carthy. The network helps show where Jon M. Carthy may publish in the future.

Co-authorship network of co-authors of Jon M. Carthy

This figure shows the co-authorship network connecting the top 25 collaborators of Jon M. Carthy. A scholar is included among the top collaborators of Jon M. Carthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon M. Carthy. Jon M. Carthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatur, Safia, Brian W. Wong, Jon M. Carthy, & Bruce M. McManus. (2016). Inhibition of vascular endothelial growth factor reduces cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 35(9). 1124–1130. 9 indexed citations
2.
Carthy, Jon M., Martin Stöter, Claudia Bellomo, et al.. (2016). Chemical regulators of epithelial plasticity reveal a nuclear receptor pathway controlling myofibroblast differentiation. Scientific Reports. 6(1). 29868–29868. 9 indexed citations
3.
Petanidis, Savvas, Efrosini Kioseoglou, Kalliopi Domvri, et al.. (2016). In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients. The International Journal of Biochemistry & Cell Biology. 74. 121–134. 29 indexed citations
4.
Carthy, Jon M., Anna Meredith, Thomas Abraham, et al.. (2015). Versican V1 Overexpression Induces a Myofibroblast-Like Phenotype in Cultured Fibroblasts. PLoS ONE. 10(7). e0133056–e0133056. 30 indexed citations
5.
Carthy, Jon M., et al.. (2015). Versican localizes to the nucleus in proliferating mesenchymal cells. Cardiovascular Pathology. 24(6). 368–374. 16 indexed citations
6.
Meredith, Anna, et al.. (2015). 1,25 Dihydroxyvitamin D3 Inhibits TGFβ1-Mediated Primary Human Cardiac Myofibroblast Activation. PLoS ONE. 10(6). e0128655–e0128655. 34 indexed citations
7.
Carthy, Jon M., Ulla Engström, Carl‐Henrik Heldin, & Aristidis Moustakas. (2015). Commercially Available Preparations of Recombinant Wnt3a Contain Non‐Wnt Related Activities Which May Activate TGF‐β Signaling. Journal of Cellular Biochemistry. 117(4). 938–945. 8 indexed citations
8.
Carthy, Jon M., Anders Sundqvist, Hans van Dam, et al.. (2015). Tamoxifen Inhibits TGF‐β‐Mediated Activation of Myofibroblasts by Blocking Non‐Smad Signaling Through ERK1/2. Journal of Cellular Physiology. 230(12). 3084–3092. 68 indexed citations
9.
Rahmani, Maziar, Jon M. Carthy, & Bruce M. McManus. (2011). Mapping of the Wnt/β-Catenin/TCF Response Elements in the Human Versican Promoter. Methods in molecular biology. 836. 35–52. 18 indexed citations
10.
Carthy, Jon M., Zongshu Luo, & Bruce M. McManus. (2011). WNT3A induces a contractile and secretory phenotype in cultured vascular smooth muscle cells that is associated with increased gap junction communication. Laboratory Investigation. 92(2). 246–255. 18 indexed citations
11.
Carthy, Jon M., et al.. (2011). Versican and CD44 in in vitro valvular interstitial cell injury and repair. Cardiovascular Pathology. 21(2). 74–82. 11 indexed citations
12.
Carthy, Jon M., Farshid S. Garmaroudi, Zongshu Luo, & Bruce M. McManus. (2011). Wnt3a Induces Myofibroblast Differentiation by Upregulating TGF-β Signaling Through SMAD2 in a β-Catenin-Dependent Manner. PLoS ONE. 6(5). e19809–e19809. 141 indexed citations
13.
Abraham, Thomas, Samuel Wadsworth, Jon M. Carthy, Dmitri V. Pechkovsky, & Bruce M. McManus. (2010). Minimally invasive imaging method based on second harmonic generation and multiphoton excitation fluorescence in translational respiratory research. Respirology. 16(1). 22–33. 12 indexed citations
14.
Abraham, Thomas, Jon M. Carthy, & Bruce M. McManus. (2009). Collagen matrix remodeling in 3-dimensional cellular space resolved using second harmonic generation and multiphoton excitation fluorescence. Journal of Structural Biology. 169(1). 36–44. 32 indexed citations
15.
Carthy, Jon M., et al.. (2009). 130: Versican Expression Induces Tissue Remodeling. The Journal of Heart and Lung Transplantation. 28(2). S111–S111. 1 indexed citations
16.
Abraham, Thomas, Jon M. Carthy, & Bruce M. McManus. (2009). Imaging of collagen matrix remodeling in three-dimensional space using second harmonic generation and two photon excitation fluorescence. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7183. 71831Z–71831Z. 1 indexed citations
17.
Carthy, Jon M., et al.. (2008). Versican induces fibroblast contraction of collagen gels. Matrix Biology. 27. 57–58. 1 indexed citations
18.
Rahmani, Maziar, et al.. (2006). Versican: signaling to transcriptional control pathwaysThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigator's Forum.. Canadian Journal of Physiology and Pharmacology. 84(1). 77–92. 84 indexed citations
19.
Rahmani, Maziar, Jon M. Carthy, Paul C. McDonald, et al.. (2005). Regulation of the Versican Promoter by the β-Catenin-T-cell Factor Complex in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 280(13). 13019–13028. 74 indexed citations
20.
Rahmani, Maziar, Jon M. Carthy, Zongshu Luo, et al.. (2004). VERSICAN PROMOTER IS A TARGET FOR THE β-CATENIN/TCF-4 TRANSCRIPTION FACTOR VIA PROTEIN KINASE B/GLYCOGEN SYNTHASE KINASE-3β SIGNALING IN VASCULAR SMOOTH MUSCLE CELLS. Cardiovascular Pathology. 13(3). 56–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026